1
NR565 / NR 565 Midterm ACTUAL EXAM
2026/2027 | Advanced Pharmacology
Fundamentals | Verified Exam Questions and
Answers 100% Correct | Grade A | Chamberlain |
Pass Guaranteed
Section I: Advanced Pharmacokinetics & Pharmacodynamics (Questions 1-25)
1. A 68-year-old male (weight 70 kg) with chronic kidney disease (CrCl 25 mL/min) is
prescribed gentamicin for sepsis. The volume of distribution (Vd) for gentamicin is 0.25 L/kg,
and the desired peak concentration is 8 mg/L. Which loading dose should be administered?
A) 100 mg IV
B) 140 mg IV
C) 175 mg IV
D) 280 mg IV
Rationale: Loading dose = desired concentration × Vd × weight. Calculation: 8 mg/L × 0.25
L/kg × 70 kg = 140 mg. In renal impairment, gentamicin's clearance is reduced but Vd remains
relatively unchanged in uncomplicated CKD. The loading dose achieves therapeutic
concentration immediately while maintenance dosing must be adjusted for reduced elimination.
Correct Answer: B
2. A 45-year-old female with atrial fibrillation on warfarin (5 mg daily, INR 2.5 stable for 6
months) develops acute diarrhea and vomiting for 48 hours. She presents with epistaxis and INR
of 4.8. Which pharmacokinetic principle BEST explains this change?
A) Increased drug absorption due to reduced GI transit time
B) Reduced hepatic metabolism due to dehydration
C) Reduced vitamin K absorption leading to enhanced warfarin effect
D) Decreased protein binding from albumin loss
,2
Rationale: Warfarin inhibits vitamin K-dependent clotting factor synthesis. Acute GI illness
reduces vitamin K absorption from the gut, amplifying warfarin's pharmacodynamic effect. This
is a PD change, not PK. The reduced vitamin K availability shifts the equilibrium toward
anticoagulation. Albumin changes would not significantly affect warfarin (highly protein-bound
but low extraction ratio).
Correct Answer: C
3. A patient on phenytoin 300 mg daily has a measured concentration of 6 mcg/mL (therapeutic
range 10-20 mcg/mL). The half-life of phenytoin at this concentration is 12 hours. If the dose is
increased to 400 mg daily, how many days are needed to reach approximately 95% of the new
steady-state concentration?
A) 2 days
B) 3 days
C) 5 days
D) 7 days
Rationale: Phenytoin exhibits Michaelis-Menten (saturable) kinetics, but at sub-therapeutic
concentrations, it approximates first-order kinetics. Time to 95% steady-state = 4.32 × half-life
(≈ 5 half-lives). With t½ of 12 hours: 5 × 12 hours = 60 hours = 2.5 days. However, as
concentration increases with higher dosing, half-life will lengthen (transition toward zero-order).
Conservative clinical estimate requires 5-7 days for full equilibration at therapeutic
concentrations.
Correct Answer: C
4. Which clinical scenario BEST demonstrates the principle of "first-pass metabolism"
significantly affecting drug bioavailability?
A) A patient receiving nitroglycerin SL who develops tolerance after 1 week
B) Morphine 30 mg PO producing lower peak plasma levels than morphine 10 mg IV
C) Lidocaine administered IV for ventricular arrhythmias due to 0% oral bioavailability
D) Propranolol showing dose-dependent increases in bioavailability with higher doses
Rationale: Propranolol exhibits saturable first-pass hepatic metabolism. At lower doses,
extensive presystemic metabolism limits bioavailability. Higher doses saturate hepatic enzymes,
allowing more drug to escape first-pass, creating non-linear increases in systemic exposure. This
pharmacokinetic phenomenon distinguishes it from simple hepatic extraction or alternative
administration routes.
Correct Answer: D
,3
5. A 72-year-old patient with NYHA Class III heart failure receives carvedilol 3.125 mg BID.
After 2 weeks, the dose is titrated to 6.25 mg BID, and the patient presents with symptomatic
hypotension and dizziness. Which parameter BEST explains this exaggerated response to dose
escalation?
A) Increased volume of distribution in heart failure
B) Decreased hepatic clearance due to reduced hepatic blood flow
C) Enhanced receptor sensitivity from upregulation during chronic heart failure
D) Accumulation of active metabolites
Rationale: Chronic heart failure causes compensatory upregulation of β-adrenergic receptors
due to chronic catecholamine exposure. When β-blockade is initiated, this creates heightened
sensitivity to sympathetic withdrawal. Even small dose increases can precipitate dramatic
hemodynamic effects due to this receptor adaptation, particularly in elderly patients with
impaired baroreceptor reflexes.
Correct Answer: C
6. Which pharmacodynamic parameter describes the dose/concentration producing 50% of the
maximum possible drug effect?
A) Efficacy (Emax)
B) Potency (EC50)
C) Therapeutic index (TD50/ED50)
D) Intrinsic activity
Rationale: EC50 represents the concentration at which 50% of maximum effect is achieved.
This defines potency—the concentration required to produce a given effect. Lower EC50
indicates higher potency. Efficacy (Emax) describes maximum effect achievable. Therapeutic
index relates safety margins. Intrinsic activity describes the ability of a ligand-receptor complex
to produce a response.
Correct Answer: B
7. A patient with status epilepticus receives lorazepam 4 mg IV. Within 2 minutes, seizure
activity stops, but 15 minutes later seizures recur. Which pharmacokinetic principle explains this
rapid loss of effect?
A) Distribution phase redistribution from CNS to peripheral tissues
B) Rapid metabolism by hepatic CYP3A4 enzymes
, 4
C) Development of acute tolerance at GABA receptors
D) Renal elimination of unbound drug
Rationale: Highly lipophilic benzodiazepines (e.g., lorazepam, diazepam) rapidly distribute
across the blood-brain barrier, producing immediate CNS effects. However, subsequent
redistribution into peripheral adipose tissues dramatically reduces CNS concentration, causing
rapid termination of clinical effect despite persistent plasma levels. This redistribution phase is
distinct from elimination.
Correct Answer: A
8. Which statement CORRECTLY describes the relationship between clearance (Cl), volume of
distribution (Vd), and elimination half-life (t½)?
A) t½ = 0.693 × (Cl/Vd)
B) t½ = 0.693 × (Vd/Cl)
C) t½ = Vd × Cl × 0.693
D) t½ = (Vd + Cl)/0.693
Rationale: Elimination half-life is determined by the volume of distribution (amount of drug
distributed) divided by clearance (rate of elimination), multiplied by the natural logarithm of 2
(0.693). This relationship demonstrates that drugs with large Vd (e.g., lipophilic drugs) or low
clearance (e.g., renal impairment) will have prolonged half-lives, affecting dosing intervals.
Correct Answer: B
9. A patient with severe liver cirrhosis (Child-Pugh Class C) is prescribed morphine 2 mg IV
PRN for pain. Which pharmacokinetic alteration poses the GREATEST risk for adverse effects?
A) Reduced hepatic blood flow increasing bioavailability
B) Increased free fraction of morphine due to hypoalbuminemia
C) Decreased glucuronidation capacity reducing active metabolite formation
D) Impaired biliary excretion causing accumulation
Rationale: Morphine is 35% protein-bound primarily to albumin. Cirrhosis-induced
hypoalbuminemia increases the free (unbound) fraction from ~35% to 50% or higher. This
pharmacologically active fraction can double, effectively doubling drug effect even with normal
total plasma concentrations. This increased free fraction coupled with reduced hepatic clearance
creates a high-risk scenario for respiratory depression.
Correct Answer: B
NR565 / NR 565 Midterm ACTUAL EXAM
2026/2027 | Advanced Pharmacology
Fundamentals | Verified Exam Questions and
Answers 100% Correct | Grade A | Chamberlain |
Pass Guaranteed
Section I: Advanced Pharmacokinetics & Pharmacodynamics (Questions 1-25)
1. A 68-year-old male (weight 70 kg) with chronic kidney disease (CrCl 25 mL/min) is
prescribed gentamicin for sepsis. The volume of distribution (Vd) for gentamicin is 0.25 L/kg,
and the desired peak concentration is 8 mg/L. Which loading dose should be administered?
A) 100 mg IV
B) 140 mg IV
C) 175 mg IV
D) 280 mg IV
Rationale: Loading dose = desired concentration × Vd × weight. Calculation: 8 mg/L × 0.25
L/kg × 70 kg = 140 mg. In renal impairment, gentamicin's clearance is reduced but Vd remains
relatively unchanged in uncomplicated CKD. The loading dose achieves therapeutic
concentration immediately while maintenance dosing must be adjusted for reduced elimination.
Correct Answer: B
2. A 45-year-old female with atrial fibrillation on warfarin (5 mg daily, INR 2.5 stable for 6
months) develops acute diarrhea and vomiting for 48 hours. She presents with epistaxis and INR
of 4.8. Which pharmacokinetic principle BEST explains this change?
A) Increased drug absorption due to reduced GI transit time
B) Reduced hepatic metabolism due to dehydration
C) Reduced vitamin K absorption leading to enhanced warfarin effect
D) Decreased protein binding from albumin loss
,2
Rationale: Warfarin inhibits vitamin K-dependent clotting factor synthesis. Acute GI illness
reduces vitamin K absorption from the gut, amplifying warfarin's pharmacodynamic effect. This
is a PD change, not PK. The reduced vitamin K availability shifts the equilibrium toward
anticoagulation. Albumin changes would not significantly affect warfarin (highly protein-bound
but low extraction ratio).
Correct Answer: C
3. A patient on phenytoin 300 mg daily has a measured concentration of 6 mcg/mL (therapeutic
range 10-20 mcg/mL). The half-life of phenytoin at this concentration is 12 hours. If the dose is
increased to 400 mg daily, how many days are needed to reach approximately 95% of the new
steady-state concentration?
A) 2 days
B) 3 days
C) 5 days
D) 7 days
Rationale: Phenytoin exhibits Michaelis-Menten (saturable) kinetics, but at sub-therapeutic
concentrations, it approximates first-order kinetics. Time to 95% steady-state = 4.32 × half-life
(≈ 5 half-lives). With t½ of 12 hours: 5 × 12 hours = 60 hours = 2.5 days. However, as
concentration increases with higher dosing, half-life will lengthen (transition toward zero-order).
Conservative clinical estimate requires 5-7 days for full equilibration at therapeutic
concentrations.
Correct Answer: C
4. Which clinical scenario BEST demonstrates the principle of "first-pass metabolism"
significantly affecting drug bioavailability?
A) A patient receiving nitroglycerin SL who develops tolerance after 1 week
B) Morphine 30 mg PO producing lower peak plasma levels than morphine 10 mg IV
C) Lidocaine administered IV for ventricular arrhythmias due to 0% oral bioavailability
D) Propranolol showing dose-dependent increases in bioavailability with higher doses
Rationale: Propranolol exhibits saturable first-pass hepatic metabolism. At lower doses,
extensive presystemic metabolism limits bioavailability. Higher doses saturate hepatic enzymes,
allowing more drug to escape first-pass, creating non-linear increases in systemic exposure. This
pharmacokinetic phenomenon distinguishes it from simple hepatic extraction or alternative
administration routes.
Correct Answer: D
,3
5. A 72-year-old patient with NYHA Class III heart failure receives carvedilol 3.125 mg BID.
After 2 weeks, the dose is titrated to 6.25 mg BID, and the patient presents with symptomatic
hypotension and dizziness. Which parameter BEST explains this exaggerated response to dose
escalation?
A) Increased volume of distribution in heart failure
B) Decreased hepatic clearance due to reduced hepatic blood flow
C) Enhanced receptor sensitivity from upregulation during chronic heart failure
D) Accumulation of active metabolites
Rationale: Chronic heart failure causes compensatory upregulation of β-adrenergic receptors
due to chronic catecholamine exposure. When β-blockade is initiated, this creates heightened
sensitivity to sympathetic withdrawal. Even small dose increases can precipitate dramatic
hemodynamic effects due to this receptor adaptation, particularly in elderly patients with
impaired baroreceptor reflexes.
Correct Answer: C
6. Which pharmacodynamic parameter describes the dose/concentration producing 50% of the
maximum possible drug effect?
A) Efficacy (Emax)
B) Potency (EC50)
C) Therapeutic index (TD50/ED50)
D) Intrinsic activity
Rationale: EC50 represents the concentration at which 50% of maximum effect is achieved.
This defines potency—the concentration required to produce a given effect. Lower EC50
indicates higher potency. Efficacy (Emax) describes maximum effect achievable. Therapeutic
index relates safety margins. Intrinsic activity describes the ability of a ligand-receptor complex
to produce a response.
Correct Answer: B
7. A patient with status epilepticus receives lorazepam 4 mg IV. Within 2 minutes, seizure
activity stops, but 15 minutes later seizures recur. Which pharmacokinetic principle explains this
rapid loss of effect?
A) Distribution phase redistribution from CNS to peripheral tissues
B) Rapid metabolism by hepatic CYP3A4 enzymes
, 4
C) Development of acute tolerance at GABA receptors
D) Renal elimination of unbound drug
Rationale: Highly lipophilic benzodiazepines (e.g., lorazepam, diazepam) rapidly distribute
across the blood-brain barrier, producing immediate CNS effects. However, subsequent
redistribution into peripheral adipose tissues dramatically reduces CNS concentration, causing
rapid termination of clinical effect despite persistent plasma levels. This redistribution phase is
distinct from elimination.
Correct Answer: A
8. Which statement CORRECTLY describes the relationship between clearance (Cl), volume of
distribution (Vd), and elimination half-life (t½)?
A) t½ = 0.693 × (Cl/Vd)
B) t½ = 0.693 × (Vd/Cl)
C) t½ = Vd × Cl × 0.693
D) t½ = (Vd + Cl)/0.693
Rationale: Elimination half-life is determined by the volume of distribution (amount of drug
distributed) divided by clearance (rate of elimination), multiplied by the natural logarithm of 2
(0.693). This relationship demonstrates that drugs with large Vd (e.g., lipophilic drugs) or low
clearance (e.g., renal impairment) will have prolonged half-lives, affecting dosing intervals.
Correct Answer: B
9. A patient with severe liver cirrhosis (Child-Pugh Class C) is prescribed morphine 2 mg IV
PRN for pain. Which pharmacokinetic alteration poses the GREATEST risk for adverse effects?
A) Reduced hepatic blood flow increasing bioavailability
B) Increased free fraction of morphine due to hypoalbuminemia
C) Decreased glucuronidation capacity reducing active metabolite formation
D) Impaired biliary excretion causing accumulation
Rationale: Morphine is 35% protein-bound primarily to albumin. Cirrhosis-induced
hypoalbuminemia increases the free (unbound) fraction from ~35% to 50% or higher. This
pharmacologically active fraction can double, effectively doubling drug effect even with normal
total plasma concentrations. This increased free fraction coupled with reduced hepatic clearance
creates a high-risk scenario for respiratory depression.
Correct Answer: B
